Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center

Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma

John F. DiPersio, Edward A. Stadtmauer, Auayporn Nademanee et al. · Blood · 2009 · 780 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Factors that influence collection and engraftment of autologous peripheral-blood stem cells.

F R Appelbaum, Scott D. Rowley, Rainer Storb et al. · Journal of Clinical Oncology · 1995 · 648 citations

Medicine, Hematology, Oncology +17

Superiority of thalidomide and dexamethasone over vincristine-doxorubicindexamethasone (VAD) as primary therapy in preparation for autologous transplantation for multiple myeloma

Michèle Cavo, Elena Zamagni, Patrizia Tosi et al. · Blood · 2005 · 366 citations

Medicine, Hematology, Oncology +16

Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma

Shaji Kumar, Angela Dispenzieri, Martha Q. Lacy et al. · Leukemia · 2007 · 352 citations

Medicine, Hematology, Oncology +14

VAD‐based regimens as primary treatment for multiple myeloma

Raymond Alexanian, Bart Barlogie, Susan L. Tucker · American Journal of Hematology · 1990 · 311 citations

Medicine, Oncology, Pharmacology +12